Antheia Appoints Dr. Chris Savile as Vice President of Business Development and Partnerships [Yahoo! Finance]
Precigen, Inc. (PGEN)
Last precigen, inc. earnings: 3/2 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
MENLO PARK, Calif. March 19, 2026 /PRNewswire/ -- Antheia , the advanced biosynthesis company delivering 21st-century pharmaceutical manufacturing and innovation, today announced the appointment of Dr. Chris Savile as Vice President, Business Development and Partnerships. Savile will drive strategic partnerships to expand Antheia's pipeline of pharmaceutical ingredients and unlock opportunities for innovation that leverage the company's advanced biosynthesis platform. Antheia (PRNewsfoto/Antheia) "As we continue building a diversified pipeline of essential drug ingredients, industry collaboration will be central to our growth," said Dr. Christina Smolke, CEO and co-founder of Antheia. "We're thrilled to bring Chris' unique blend of scientific depth and commercial leadership to our team. His proven track record of translating complex biotechnology into meaningful business opportunities will be critical to expanding the impact of our platform." Savile brings more than 20 years of
Show less
Read more
Impact Snapshot
Event Time:
PGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PGEN alerts
High impacting Precigen, Inc. news events
Weekly update
A roundup of the hottest topics
PGEN
News
- Assessing Precigen (PGEN) Valuation After Recent Share Price Weakness And Conflicting Fair Value Estimates [Yahoo! Finance]Yahoo! Finance
- Precigen (PGEN) was upgraded by Zacks Research from "strong sell" to "hold".MarketBeat
- Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25PR Newswire
- Precigen (PGEN) Surged Following the Early Approval of Papziemos [Yahoo! Finance]Yahoo! Finance
- Precigen: PAPZIMEOS Is Delivering For This Under-The-Radar Biotech [Seeking Alpha]Seeking Alpha
PGEN
Earnings
- 11/13/25 - Miss
PGEN
Sec Filings
- 3/20/26 - Form 4
- 3/20/26 - Form 4
- 3/20/26 - Form 4
- PGEN's page on the SEC website